期刊
出版社
WILEY
DOI: 10.1002/dad2.12107
关键词
Alzheimer's disease; amyloid; depression; subjective cognitive decline
资金
- National Institutes of Health-National Institute on Aging
- Eli Lilly and Company
- Alzheimer's Association
- GHR Foundation
- Accelerating Medicines Partnership
Introduction: Understanding the associations among depression, subjective cognitive decline, and prodromal Alzheimer's disease (AD) has important implications for both depression and dementia screening in older adults. The Geriatric Depression Scale (GDS) is a depression screening tool for older adults that queries memory concerns. To determine whether depression symptoms on the GDS (15-item version), including self-reported memory problems, differ by levels of brain amyloid beta (A beta), a pathological hallmark of early stage AD, we investigated potential measurement bias with regard to A beta level. We also examined measurement bias attributable to level of cognitive functioning and sex as positive controls. Methods: We examined 3961 cognitively normal older adults from the A4/LEARN Study. We used the MIMIC (multiple indicators, multiple causes) approach to detect measurement bias. Results: We found measurement bias with small-to-moderate range effect sizes in several GDS-15 items with respect to A beta level, cognitive functioning, and sex. There was negligible impact of measurement bias attributable to A beta level on overall depressive symptom level. Discussion: GDS-15 item responses are sensitive to A beta burden, cognitive functioning, and sex over and above what would be expected given the effect of those factors on depressive symptom severity overall. However, these direct effects for GDS item measurement bias are of small magnitude and do not appreciably impact the validity of inferences about depression based on the GDS-15.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据